Omx AB - OMX- Profile

Home » Directory » Financial Services » Investment Banking & Brokerage » Exchanges » Omx AB » Profile
Website: http://www.omhex.com

Phone: +46 8 405 60 00
Address:
Tullvaktsvagen 15
10578 Stockholm,
Company Description
OMX AB. The Group's principal activities are the provision of products and services for trading in financial instruments and commodities. The Group operates in the following three segments: OMX Exchanges, OMX Technology and Information Services/New Markets. OMX Exchange offers access to approximately 80 percent of the Nordic and Baltic securities markets which includes stock exchanges in Copenhagen, Stockholm, Helsinki, Tallinn, Riga and Vilnius. OMX Technology provides solutions and services, transaction technology, processing and outsourcing based on proven technology. Information Services & New Markets comprises OMX's information services, the exchanges in the Baltic States and Broker Services. It also includes exploring future business opportunities in new markets. In 2006, the Group acquired Computershare Markets Technology. OMX Exchanges accounted for 48% of 2006 gross revenues; OMX Technology, 35% & OMX Information Services/New Markets, 17%
Key People
Chairman Dr. Olof Stenhammar
Managing Director Magnus Boecker
Finance Director Kristina Schauman

Related Business Topics
Breaking News
Reuters - November 26, 2009 11:57 PM
STOCKHOLM, Sweden, Nov. 27, 2009 (GLOBE NEWSWIRE) -- Diamyd Medical's Annual Report for 2008/2009 from today is available in Swedish on the company website, www.diamyd.com. A printed Annual Report can be ordered by mail to Diamyd Medical, Linnegatan 89 ...
Forbes.com - November 18, 2009 1:40 AM
STOCKHOLM, Nov 18 (Reuters) - Swedbank AB: * Sells shares in Tallinn exchange to NASDAQ OMX to improve ability to develop more liquid baltic capital markets * Says held ...
Reuters - November 13, 2009 12:48 AM
LUND, Sweden--(Business Wire)-- BioInvent International AB (OMXS: BINV) has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED (TSE: 4568) for the development of therapeutic antibodies against ...
Forbes.com - November 13, 2009 12:04 AM
BusinessWire - BioInvent International AB (OMXS: BINV) has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED (TSE: 4568) for the development of therapeutic antibodies against multiple targets. Under ...
Forbes.com - November 04, 2009 8:40 AM
BusinessWire - Regulatory News: TeliaSonera (STO:TLSN)(HEX:TLS1V)(LSE:TEE)(Nasdaq:TLSN) today issued a Eurobond of EUR 600 million under its existing EUR 7 billion EMTN (Euro Medium Term Note) programme. The Re-offer yield was set at 4.825% p.a. ...
Overview  |  Profile